A synthetic M protein peptide synergizes with a CXC chemokine protease to induce vaccine-mediated protection against virulent streptococcal pyoderma and bacteremia.
about
Accelerating the development of a group A Streptococcus vaccine: an urgent public health needStreptococcal Immunity Is Constrained by Lack of Immunological Memory following a Single Episode of Pyoderma.Complement inhibition by Sarcoptes scabiei protects Streptococcus pyogenes - An in vitro study to unravel the molecular mechanisms behind the poorly understood predilection of S. pyogenes to infect mite-induced skin lesions.Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease ModelsNovel platform technology for modular mucosal vaccine that protects against streptococcus.Strategic development of the conserved region of the M protein and other candidates as vaccines to prevent infection with group A streptococci.Development of Group A streptococcal vaccines: an unmet global health need.Preclinical immunogenicity and safety of a Group A streptococcal M protein-based vaccine candidate.Combinatorial Synthetic Peptide Vaccine Strategy Protects against Hypervirulent CovR/S Mutant Streptococci.Enhancing Vaccine Efficacy by Engineering a Complex Synthetic Peptide To Become a Super Immunogen.Physicochemical characterisation, immunogenicity and protective efficacy of a lead streptococcal vaccine: progress towards Phase I trial.Skin infection boosts memory B-cells specific for a cryptic vaccine epitope of group A streptococcus and broadens the immune response to enhance vaccine efficacy.
P2860
Q26739210-9C495345-9203-4921-8BFE-AE0E8321DE63Q36233908-310A62AC-44C4-4E5D-B16B-C7AA2C72C130Q36302638-3F6920EF-3DA0-4D1E-B320-E9B871AA21F6Q37027300-DDB58D66-2842-41E6-8226-40E325C48F7FQ37504796-D1C9CF2F-14A4-47A9-8FC9-9375C81CDD8CQ38612165-1ADAF71A-3F2F-4670-824E-170DBBE24A7FQ38631048-F9EBB42B-CD01-411A-9A97-AE0D4AF9FB80Q38897169-73D1E116-F531-43E5-BD6E-74ACD56EEE70Q39926669-99287C00-1AB4-4037-BA8D-72E5CF2DB397Q40048109-3B3B8159-34CD-4976-9A66-A136E6B971A6Q47154849-D51A5285-6F6C-43D3-A9FC-320DCFCAE4F2Q54218671-1CCA8AEF-11C6-4710-BF32-79F7A0C685DA
P2860
A synthetic M protein peptide synergizes with a CXC chemokine protease to induce vaccine-mediated protection against virulent streptococcal pyoderma and bacteremia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
A synthetic M protein peptide ...... occal pyoderma and bacteremia.
@en
A synthetic M protein peptide ...... occal pyoderma and bacteremia.
@nl
type
label
A synthetic M protein peptide ...... occal pyoderma and bacteremia.
@en
A synthetic M protein peptide ...... occal pyoderma and bacteremia.
@nl
prefLabel
A synthetic M protein peptide ...... occal pyoderma and bacteremia.
@en
A synthetic M protein peptide ...... occal pyoderma and bacteremia.
@nl
P2093
P356
P1476
A synthetic M protein peptide ...... occal pyoderma and bacteremia.
@en
P2093
Emma Langshaw
Jon Hartas
Manisha Pandey
Michael R Batzloff
P304
P356
10.4049/JIMMUNOL.1500157
P407
P577
2015-05-15T00:00:00Z